Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine for sedation and delirium in elderly ventilated patients
NCT02225210Phase 4Unknown
- Sponsor
- Fuling Central Hospital
- Start
- Sep 2014
- Primary completion
- Jun 2015
- Modality
- Small Molecules
01
Overview
Phase 4, randomised trial of dexmedetomidine in delirium, sponsored by Fuling Central Hospital. Primary endpoint: Changes in blood pressure at 48 hours. Status: unknown.
02
Drugs
dexmedetomidine
03
Conditions
delirium
Beyond the preview
Go deeper on NCT02225210.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02225210.